At a glance
- Originator Novo Nordisk
- Class Antihyperglycaemics; Small molecules
- Mechanism of Action Glucagon receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetes mellitus
Most Recent Events
- 08 Jun 2001 No-Development-Reported for Diabetes mellitus in Denmark (Unknown route)
- 09 Sep 1998 New profile
- 09 Sep 1998 Preclinical development for Diabetes mellitus in Denmark (Unknown route)